Life Tech's Food Pathogen Detection Methods Approved by Australian Government
News Dec 17, 2013
Life Technologies announced that its MicroSEQ® Real-Time PCR workflow was officially approved by the Australian Government, Department of Agriculture as an Approved Test Method to detect pathogens in export meat and meat products.
Australia is a major exporter of food and the second largest exporter of beef in the world. When exporting food, many products are subject to testing as part of the trade arrangements between Australia and importing countries. Many countries require test methods under their country's regulation including methods that are prior to the approval by the government of Australia. Therefore, microbiological testing which is commonly agreed by both exporting and importing countries following government approved methods at regulated laboratories is essential to ensure the quality of the export products.
The Department of Agriculture in Australia has reviewed the validation data and granted approval for the use of the Life Technologies' MicroSEQ® Real-Time PCR workflows for the testing of Australian meat and meat products for export. The workflows approved are used to detect three pathogens, E. coli O157:H7 (in raw ground beef and beef trim), Salmonella and Listeria monocytogenes (in meat and meat products), which are the major food pathogens associated with meats and meat products. The approved total workflows include use of PrepSEQTM Rapid Spin Sample Preparation Kit or Automated PrepSEQTM Nucleic Acid Extraction Kit, MicroSEQ® Detection Kits and 7500 Fast Real-Time PCR Instrument, guided by the RapidFinderTM Express Software to gain data.
"We believe that this approval warrants our dedication as a global leader to food safety," said Gerard Davis, Director of Animal Health, Food Safety & Environment, Asia Pacific and Japan region of Life Technologies. "We are committed to offer integrated solutions to provide faster, accurate and innovative technologies to food producers, service labs and governments in every region across the globe."
"Grounded in the community, we offer wide solutions to researchers and institutions in fields such as Life Science, Medical Science, Food and Animal Safety and Forensics," said Owen Wright, General Manager of Australia and New Zealand of Life Technologies. "We are glad that with our global expertise, we could contribute to the Australian and global food industry."
Summary of Methodologies for these products are available on the Department of Agriculture's website.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.